Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
MicroPort Scientific ( (HK:0853) ) has shared an update.
MicroPort Scientific Corporation has announced the appointment of Mr. Jonathan W. Chen as the Rotating Co-chief Executive Officer, effective June 27, 2025. This strategic move is part of the company’s efforts to strengthen its internationalization and professionalization, as well as to develop a young management talent pipeline. Additionally, Dr. Brian Yale Chang has been appointed as the Chief Medical Officer, responsible for overseeing medical affairs strategies and providing expert medical insights across the company’s global operations. These appointments are expected to inject new momentum into MicroPort’s strategic execution and sustainable growth, enhancing its operational capabilities and expanding its global presence.
The most recent analyst rating on (HK:0853) stock is a Hold with a HK$7.30 price target. To see the full list of analyst forecasts on MicroPort Scientific stock, see the HK:0853 Stock Forecast page.
More about MicroPort Scientific
MicroPort Scientific Corporation operates in the medical devices industry, focusing on international business and professional operational capabilities. The company is committed to internationalization and professionalization, aiming to enhance its global corporate governance standards and expand its development footprint overseas.
Average Trading Volume: 18,727,862
Technical Sentiment Signal: Buy
Current Market Cap: HK$15.65B
Find detailed analytics on 0853 stock on TipRanks’ Stock Analysis page.